MCL1 and renal carcinoma: In conclusion, our results suggested that YM155 induces TRAIL-mediated apoptosis through cathepsin S-dependent down-regulation of Mcl-1 expression and down-regulation of c-FLIP expression via down-regulation of NF-κB transcriptional activity in human renal cancer cells.